Survival Impact of Second-Line Immune Checkpoint Inhibitors in Older Patients With Advanced Squamous-Cell NSCLC: Post Hoc Analysis of the CAPITAL Study

CONCLUSIONS: We found that second-line ICI treatment seemed to have a little impact on OS.PMID:37304652 | PMC:PMC10250914 | DOI:10.1016/j.jtocrr.2023.100514

Source: Clinical Lung Cancer - June 12, 2023 Category: Cancer & Oncology Authors: Yoshihito Kogure Akiko Kada Hiroya Hashimoto Shinji Atagi Yuichi Takiguchi Hideo Saka Noriyuki Ebi Akira Inoue Takayasu Kurata Yuka Fujita Yoichi Nishii Hidetoshi Itani Takeo Endo Akiko M Saito Takuo Shibayama Nobuyuki Yamamoto Akihiko Gemma Source Type: research